<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="iso-abbrev">PLoS Comput. Biol</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6762205</article-id><article-id pub-id-type="pmid">31525184</article-id><article-id pub-id-type="publisher-id">PCOMPBIOL-D-18-01673</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1007111</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject><subj-group><subject>Vaccines</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Influenza</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Earth Sciences</subject><subj-group><subject>Geography</subject><subj-group><subject>Human Geography</subject><subj-group><subject>Human Mobility</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social Sciences</subject><subj-group><subject>Human Geography</subject><subj-group><subject>Human Mobility</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Preventive Medicine</subject><subj-group><subject>Vaccination and Immunization</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccine Development</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Immunology</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccine Development</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Preventive Medicine</subject><subj-group><subject>Vaccination and Immunization</subject><subj-group><subject>Vaccine Development</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Infectious Disease Control</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Simulation and Modeling</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Physical Sciences</subject><subj-group><subject>Mathematics</subject><subj-group><subject>Applied Mathematics</subject><subj-group><subject>Algorithms</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Simulation and Modeling</subject><subj-group><subject>Algorithms</subject></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Optimizing spatial allocation of seasonal influenza vaccine under temporal constraints</article-title><alt-title alt-title-type="running-head">Spatial optimization of seasonal influenza vaccine</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0874-8692</contrib-id><name><surname>Venkatramanan</surname><given-names>Srinivasan</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Chen</surname><given-names>Jiangzhuo</given-names></name><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7396-0350</contrib-id><name><surname>Fadikar</surname><given-names>Arindam</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Software</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gupta</surname><given-names>Sandeep</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff004"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Higdon</surname><given-names>Dave</given-names></name><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0793-6082</contrib-id><name><surname>Lewis</surname><given-names>Bryan</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Marathe</surname><given-names>Madhav</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-3363-2947</contrib-id><name><surname>Mortveit</surname><given-names>Henning</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vullikanti</surname><given-names>Anil</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib></contrib-group><aff id="aff001">
<label>1</label>
<addr-line>Biocomplexity Institute &#x00026; Initiative, University of Virginia, Charlottesville, Virginia, United States of America</addr-line>
</aff><aff id="aff002">
<label>2</label>
<addr-line>Department of Statistics, Virginia Tech, Blacksburg, Virginia, United States of America</addr-line>
</aff><aff id="aff003">
<label>3</label>
<addr-line>Fralin Life Science Institute, Virginia Tech, Blacksburg, Virginia, United States of America</addr-line>
</aff><aff id="aff004">
<label>4</label>
<addr-line>Biocomplexity Institute, Virginia Tech, Blacksburg, Virginia, United States of America</addr-line>
</aff><aff id="aff005">
<label>5</label>
<addr-line>Department of Computer Science, University of Virginia, Charlottesville, Virginia, United States of America</addr-line>
</aff><aff id="aff006">
<label>6</label>
<addr-line>Department of Engineering Systems and Environment, University of Virginia, Charlottesville, Virginia, United States of America</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Viboud</surname><given-names>Cecile</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>National Institutes of Health, UNITED STATES</addr-line>
</aff><author-notes><fn fn-type="COI-statement" id="coi001"><p>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>srini@virginia.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>16</day><month>9</month><year>2019</year></pub-date><volume>15</volume><issue>9</issue><elocation-id>e1007111</elocation-id><history><date date-type="received"><day>28</day><month>9</month><year>2018</year></date><date date-type="accepted"><day>17</day><month>5</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 Venkatramanan et al</copyright-statement><copyright-year>2019</copyright-year><copyright-holder>Venkatramanan et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pcbi.1007111.pdf"/><abstract><p>Prophylactic interventions such as vaccine allocation are some of the most effective public health policy planning tools. The supply of vaccines, however, is limited and an important challenge is to optimally allocate the vaccines to minimize epidemic impact. This resource allocation question (which we refer to as V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc>) has multiple dimensions: when, where, to whom, etc. Most of the existing literature in this topic deals with the latter (to whom), proposing policies that prioritize individuals by age and disease risk. However, since seasonal influenza spread has a typical spatial trend, and due to the temporal constraints enforced by the availability schedule, the when and where problems become equally, if not more, relevant. In this paper, we study the V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> problem in the context of seasonal influenza spread in the United States. We develop a national scale metapopulation model for influenza that integrates both short and long distance human mobility, along with realistic data on vaccine uptake. We also design G<sc>reedy</sc>A<sc>lloc</sc>, a greedy algorithm for allocating the vaccine supply at the state level under temporal constraints and show that such a strategy improves over the current baseline of pro-rata allocation, and the improvement is more pronounced for higher vaccine efficacy and moderate flu season intensity. Further, the resulting strategy resembles a ring vaccination applied spatiallyacross the US.</p></abstract><abstract abstract-type="summary"><title>Author summary</title><p>Annual vaccination campaigns continue to be one of the prime measures which help alleviate the burden of seasonal influenza. Due to production and logistic constraints, there is a need for prioritization policies associated with vaccine deployment. While there is general consensus on age-based or risk-based prioritization, spatial optimization of vaccine allocation has not yet been explored in sufficient detail. In order to do this, we develop a mechanistic model of influenza spread across the United States, and propose a greedy mechanism for spatial optimization. We test the methodology on different realistic scenarios with temporal constraints on vaccine production.</p></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000774</institution-id><institution>Defense Threat Reduction Agency</institution></institution-wrap></funding-source><award-id>HDTRA1-11-D-0016-000</award-id><principal-award-recipient><name><surname>Marathe</surname><given-names>Madhav</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>5U01GM070694</award-id></award-group><award-group id="award003"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>1R01GM109718</award-id></award-group><funding-statement>This work has been partially supported by DTRA CNIMS Contract HDTRA1-11-D-0016-0001, NIH MIDAS Grant 5U01GM070694, NIH Grant 1R01GM109718, NSF DIBBS Grant ACI-1443054, NSF EAGER Grant CMMI-1745207, NSF BIG DATA Grant IIS-1633028 and NSF CRISP 2.0 Grant 1832587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="8"/><table-count count="0"/><page-count count="17"/></counts><custom-meta-group><custom-meta><meta-name>PLOS Publication Stage</meta-name><meta-value>vor-update-to-uncorrected-proof</meta-value></custom-meta><custom-meta><meta-name>Publication Update</meta-name><meta-value>2019-09-26</meta-value></custom-meta><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All data used in the paper are from public databases. The data used for developing the model came from American FactFinder (factfinder.census.gov), and Bureau of Transportation Statistics (bts.gov). All data pertaining to influenza activity and associated vaccine coverage were obtained from CDC (<ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov">www.cdc.gov</ext-link>).</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All data used in the paper are from public databases. The data used for developing the model came from American FactFinder (factfinder.census.gov), and Bureau of Transportation Statistics (bts.gov). All data pertaining to influenza activity and associated vaccine coverage were obtained from CDC (<ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov">www.cdc.gov</ext-link>).</p></notes></front><body><sec sec-type="intro" id="sec001"><title>Introduction</title><p>Infectious diseases are the largest cause of human mortality worldwide, leading to over 13 million deaths a year [<xref rid="pcbi.1007111.ref001" ref-type="bibr">1</xref>]. Respiratory diseases alone account for a large fraction of these infections&#x02014;CDC reports that the buden of illness during 2017-18 influenza season was high in the United States, with an estimated 48.8 million illnesses and 959,000 hospitalizations [<xref rid="pcbi.1007111.ref033" ref-type="bibr">33</xref>], higher than any season since the 2009 pandemic. Therefore, controlling the spread of infectious diseases, especially influenza, remains an important priority for local, state, and federal governments in the US and countries worldwide. Pharmaceutical interventions (PI) such as the use of prophylactic vaccinations and anti-viral drugs remain one of the most effective methods for controlling the spread of infectious diseases, e.g., [<xref rid="pcbi.1007111.ref002" ref-type="bibr">2</xref>], [<xref rid="pcbi.1007111.ref003" ref-type="bibr">3</xref>]. However, these interventions are constrained by limited resource supply and the high logistics cost of delivering them over a large geographical region. These limitations have been an actively studied topic in public health policy research. The primary objective here is to devise allocation and distribution strategies to improve the overall effectiveness of the limited supply of vaccines. In this paper, we denote this problem as V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc>. Most of the existing literature has focused on identifying whom to allocate the vaccines to, based on age and disease risk [<xref rid="pcbi.1007111.ref005" ref-type="bibr">5</xref>] [<xref rid="pcbi.1007111.ref006" ref-type="bibr">6</xref>]. However, it is widely understood that seasonal influenza exhibits typical spatial trends [<xref rid="pcbi.1007111.ref007" ref-type="bibr">7</xref>]. Further, the vaccine allocation problem is temporally constrained by the production and availability schedule, while most prior studies on epidemic interventions have primarily focused on static allocation before the start of the epidemic [<xref rid="pcbi.1007111.ref002" ref-type="bibr">2</xref>]. Thus the when and where aspects of allocation become equally, if not more, relevant. In [<xref rid="pcbi.1007111.ref008" ref-type="bibr">8</xref>], the authors studied vaccine allocation and distribution during the 2009 H1N1 pandemic and found that for many states, the vaccines arrived far too late to be useful. While the authors define possible alternatives for the pro-rata vaccine distribution using axiomatic Operations Research (OR) models, in this paper, we adopt a simulation optimization approach, by using a mechanistic model of influenza spread across the US.</p><p>Solving V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> is challenging due to multiple related factors. Epidemic spread is a very complex phenomenon, and is typically modeled by the SEIR class of non-linear models. Human contacts and mobility play a crucial role in the dynamics of epidemic spread [<xref rid="pcbi.1007111.ref004" ref-type="bibr">4</xref>] [<xref rid="pcbi.1007111.ref009" ref-type="bibr">9</xref>]. Therefore, solving V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> requires a combination of the modeling of human mobility and epidemic spread, and designing a strategy for optimizing the allocation of vaccines subject to availability constraints.</p><sec id="sec002"><title>Related work</title><p>There is an abundance of literature on the modeling, analysis, and control of epidemics. We briefly mention three areas that are closely related to our paper, namely, mobility modeling, disease modeling, and designing interventions to control the spread of epidemics. We refer to [<xref rid="pcbi.1007111.ref011" ref-type="bibr">11</xref>] [<xref rid="pcbi.1007111.ref012" ref-type="bibr">12</xref>] for surveys on these topics.</p><sec id="sec003"><title>Modeling social contact networks and human mobility</title><p>There is very limited data on social contact networks and human mobility, and so there has been a lot of work on developing realistic models using different kinds of datasets. Eubank et al. [<xref rid="pcbi.1007111.ref004" ref-type="bibr">4</xref>] developed a first principles based approach for constructing a realistic synthetic population by integrating over a dozen public and commercial datasets. Coarser models for some countries have been constructed using census and Landscan data, e.g., [<xref rid="pcbi.1007111.ref013" ref-type="bibr">13</xref>] [<xref rid="pcbi.1007111.ref015" ref-type="bibr">15</xref>]. However, none of these approaches considers long-distance travel outside an urban region. One of the earliest approaches for considering such travel was by Colizza et al. [<xref rid="pcbi.1007111.ref009" ref-type="bibr">9</xref>], who use information from airline data to construct a network-based representation of cities across the globe. However, airline flow does not account for all of spatial mobility, especially within the US. In [<xref rid="pcbi.1007111.ref010" ref-type="bibr">10</xref>], the authors construct a radiation model to predict commuter flows in the United States using data on road networks. Especially in the context of national scale disease spread, it is essential to have a model that combines both short-range and long-range human mobility in the United States.</p></sec><sec id="sec004"><title>Disease modeling</title><p>There are a number of variants of the SEIR type of models for disease spread, and their applicability depends on the specific assumptions that hold. The most commonly used models are compartmental in nature, assuming well-mixed populations within each compartment. A number of variants have been proposed, including stochastic models, multiple compartments to represent various subpopulations, branching processes, chain-binomial models, etc. Colizza et al. [<xref rid="pcbi.1007111.ref009" ref-type="bibr">9</xref>] use a patch model of the form we study in this paper. They study the role of long distance travel in the spread of epidemics, and use it to explain the SARS outbreak and to forecast other outbreaks. A different approach that is more suitable for heterogeneous populations is based on a network abstraction [<xref rid="pcbi.1007111.ref004" ref-type="bibr">4</xref>]. A lot of data is needed for developing such network-based models, and such models are usually computationally more intensive.</p></sec><sec id="sec005"><title>Designing interventions</title><p>Most compartmental models that have been used for studying optimal interventions are relatively simple, and can be solved using simple black-box optimization methods. An example is the work of Medlock et al. [<xref rid="pcbi.1007111.ref002" ref-type="bibr">2</xref>], who consider the problem of designing an optimal vaccine allocation for the 2009 H1N1 outbreak. They use an age-based coupled ODE model, and observe that the optimal solution is different from the CDC recommendation at that time. Similar studies have been done for other outbreaks, e.g., [<xref rid="pcbi.1007111.ref016" ref-type="bibr">16</xref>], who observe that prioritization of high-risk individuals leads to more effective strategies. However, most studies for designing vaccination policies do not take into account the spatiotemporal spread dynamics of seasonal influenza, nor the temporal constraints in vaccine production schedule. Thus there is need for coupling a mechanistic model of national-scale influenza spread with realistic vaccine uptake information for deriving an effective vaccine allocation algorithm.</p></sec></sec><sec id="sec006"><title>Our results</title><p>We develop a framework for national seasonal/pandemic influenza planning using realistic datasets, a mechanistic model of disease spread, and a greedy optimization algorithm for vaccine allocation. Our specific contributions are discussed below.</p><sec id="sec007"><title>National-scale influenza model</title><p>We develop a national-scale metapopulation model for the spread of influenza by integrating both local and long-distance travel within the United States. We combine data on commuter mobility from the American Community Survey (ACS) with domestic airline passenger data from the Bureau of Transportation Statistics (BTS) to capture human mobility across the country. Next, we adopt a metapopulation approach to simulate epidemic spread at the spatial resolution of counties (patches) wherein the temporal travel matrix is used to represent the flow of people between these patches. While similar models exist in the literature [<xref rid="pcbi.1007111.ref017" ref-type="bibr">17</xref>], this is one of the first models to integrate realistic datasets on vaccine uptake, allowing us to address the V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> problem.</p></sec><sec id="sec008"><title>Multi-stage Spatio-temporal calibration</title><p>Challenges in calibrating such a complex model include: (a) model non-linearity, (b) large number of parameters, (c) multiple spatio-temporal characteristics to calibrate to (regional attack size, peak timing, etc.), (d) lack of standardized and accurate infection counts. We use two-stage posterior exploration via importance sampling to calibrate the disease model to the total attack size (number of infections) and peak timings of the ten HHS (Health and Human Services) Regions. While peak timings for HHS regions can be obtained from the CDC ILINet (Influenza-like Illness Outpatient Surveillance Network) data, we use a novel approach to estimate total attack size for each region, and demonstrate the calibration performance for 2014-15 influenza season.</p></sec><sec id="sec009"><title>Vaccine allocation optimization</title><p>We develop a heuristic for finding a spatio-temporal vaccine allocation using a greedy strategy G<sc>reedy</sc>A<sc>lloc</sc> with a lookahead parameter, under a fixed vaccine availability schedule. We evaluate the algorithm&#x02019;s performance by comparing it against a population proportional allocation strategy (baseline). Some of our key findings are: (a) For the scenario under consideration, G<sc>reedy</sc>A<sc>lloc</sc> leads to considerable reduction in the total attack size compared to the baseline; (b) the performance of G<sc>reedy</sc>A<sc>lloc</sc> improves with vaccine efficacy, and for influenza seasons with moderate intensity; (c) the identified vaccine allocation strategy resembles a ring-vaccination, applied spatially for the state-level adjacency matrix of the US.</p><p>The overall framework that implements the steps above is shown in <xref ref-type="fig" rid="pcbi.1007111.g001">Fig 1</xref>. The modular approach allows the refinement of each module, when novel datasets, algorithms, and modeling techniques become available. In the Materials and Methods section, we briefly describe the key ideas involved in construction of the national influenza model, the calibration procedure and the vaccine allocation algorithm. We refer the reader to the <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods for more details on each of these modules. We then present the results of calibration and vaccine allocation using 2014-15 season data as a running example. A preliminary version of the model and early results for V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> were reported in [<xref rid="pcbi.1007111.ref018" ref-type="bibr">18</xref>], and the current paper includes improved calibration process and provides more realistic estimates for the effectiveness of vaccine allocation. We have also made the national simulation model code and associated data available online [<xref rid="pcbi.1007111.ref029" ref-type="bibr">29</xref>].</p><fig id="pcbi.1007111.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g001</object-id><label>Fig 1</label><caption><title>System diagram.</title><p>Datasets used in the study are listed on top, and the four main modules of our framework are highlighted in the system diagram. The Travel Module uses long distance airline travel data and short-range commuter flow data to construct the county to county temporal travel matrix. This is used by the Disease Dynamics Module for simulating national scale epidemic spread via the metapopulation model. Additional inputs to this module include the seeding and vaccination schedule, disease model parameters, and vaccine efficacy. While some of these are fixed based on the study design, the Calibration Module uses historical incidence data to estimate the remaining disease model parameters. The calibrated disease model is then used as an oracle to compute the optimized vaccine allocation in the Optimization Module.</p></caption><graphic xlink:href="pcbi.1007111.g001"/></fig></sec></sec></sec><sec sec-type="materials|methods" id="sec010"><title>Materials and methods</title><sec id="sec011"><title>National-scale influenza model</title><p>Our approach in building the national scale model involves two broad steps:</p><list list-type="bullet"><list-item><p>Developing a model of national level mobility that yields estimates of the fractions <inline-formula id="pcbi.1007111.e001"><alternatives><graphic xlink:href="pcbi.1007111.e001.jpg" id="pcbi.1007111.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:msubsup><mml:mo>&#x00398;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> moving from county <italic>i</italic> to county <italic>j</italic> on day <italic>t</italic>.</p></list-item><list-item><p>Developing the metapopulation model that uses &#x00398; and a realistic vaccine allocation schedule <italic>X</italic> to produce the spatiotemporal spread of influenza and in particular, to compute the national attack size <italic>f</italic>(<italic>X</italic>).</p></list-item></list><sec id="sec012"><title>Travel module</title><p>The purpose of the travel module is to generate the temporal travel matrix &#x00398; representing flow of people between the patches (i.e., counties) on a daily basis. Each entry <inline-formula id="pcbi.1007111.e002"><alternatives><graphic xlink:href="pcbi.1007111.e002.jpg" id="pcbi.1007111.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:msubsup><mml:mo>&#x00398;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> of the travel matrix represents the fraction of individuals in patch <italic>i</italic> spending their time in patch <italic>j</italic> on day <italic>t</italic>. The travel matrix &#x00398; is synthesized using datasets pertaining to commuter flow and domestic airline traffic. These datasets are visualized in <xref ref-type="fig" rid="pcbi.1007111.g002">Fig 2</xref>.</p><fig id="pcbi.1007111.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g002</object-id><label>Fig 2</label><caption><title>Travel datasets.</title><p>Datasets used to capture short-range and long-range mobilities in the United States are depicted as networks on top (commuter data on the left, airline data on the right). Commuter data is shown between counties, whereas airline network is shown for key domestic airports in the United States for a chosen month (January). The distribution of flow volume with respect to pairwise county distances in shown as heatmaps for both the commuter and airline data. Airline flows are fractional because they are mapped to the counties that are served by them.</p></caption><graphic xlink:href="pcbi.1007111.g002"/></fig></sec><sec id="sec013"><title>Commuter data</title><p>The commuter flow dataset is obtained through the American Community Survey (ACS) [<xref rid="pcbi.1007111.ref019" ref-type="bibr">19</xref>] that, among other things, surveys individuals for their county of residence and county of workplace. ACS then provides population adjusted estimates of number of commuters between any pair of counties for a typical day. <xref ref-type="fig" rid="pcbi.1007111.g002">Fig 2</xref> shows relationship between number of commuters from a source county to a destination county, and the distance between these counties. Other than the high volume of self-loop flows, most of the flows are concentrated in the 10&#x02013;100 miles range.</p></sec><sec id="sec014"><title>Domestic airline data</title><p>Domestic airline flow data is obtained from the Bureau of Transportation Statistics (BTS) [<xref rid="pcbi.1007111.ref020" ref-type="bibr">20</xref>]. For a given year, this dataset provides the monthly total number of passengers who flew end-to-end between any two major airports. <xref ref-type="fig" rid="pcbi.1007111.g002">Fig 2</xref> shows the number of airline passengers between counties, for a sample month. Contrasting this with that commuter flows, we find the large volume flows are concentrated in the 100&#x02013;1000 miles range. In order to integrate this dataset with the county-level commuter mobility, we first identify the catchment area of each airport (defined as 120 miles surrounding the airport), and apportion the airport flows to counties based on their population in area of intersetion with the catchment area. We also distribute the monthly number of passengers uniformly through the month to get a daily count. Unlike a daily commuter, an airline passenger tends to stay longer in the visiting county. Therefore the effective number of airline passengers in the visiting county is obtained by scaling the flow by stay duration (in our model, we set the average stay duration as 3 days). More details on the travel network construction are provided in the <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods.</p></sec><sec id="sec015"><title>Disease dynamics module</title><p>Consider a population of individuals each of whom can be in one of the following states: Susceptible (S), Exposed (E), Infected (I), Recovered/Removed (R), Vaccinated (V). Compartmental models operate under a homogeneous mixing assumption, i.e., every individual can directly infect any other individual. Initially, the entire population is susceptible, except for a few initial infections possibly due to external contact. The disease progression is modeled by the evolution of number of individuals in each of the disease states, often described by a difference or differential equation.</p><p>Within each patch, we use an SEIRV model, and connect the patches using the travel matrix &#x00398;<sup><italic>t</italic></sup>. When we extend the model for multiple patches, susceptible individuals can be infected by infectious individuals from other patches. This depends on the fraction of individuals moving from county <italic>i</italic> to county <italic>j</italic> on any given day, estimated using the temporal travel matrix &#x00398;<sup><italic>t</italic></sup>.</p><p>The temporal travel matrix <inline-formula id="pcbi.1007111.e003"><alternatives><graphic xlink:href="pcbi.1007111.e003.jpg" id="pcbi.1007111.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:msubsup><mml:mo>&#x00398;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula> is used to calculate the force of infection among patches, without actually moving infected individuals around (i.e., virtual dispersal) [<xref rid="pcbi.1007111.ref021" ref-type="bibr">21</xref>]. We compute the conditional force of infection for an individual present in patch <italic>j</italic> by using the effective populations due to mobility. We can then calculate the unconditioned force of infection on a susceptible individual from patch <italic>i</italic>, as a component-wise product of (<italic>a</italic>) the probability of the individual being in a patch <italic>j</italic> (<inline-formula id="pcbi.1007111.e004"><alternatives><graphic xlink:href="pcbi.1007111.e004.jpg" id="pcbi.1007111.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:msubsup><mml:mo>&#x00398;</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msubsup></mml:math></alternatives></inline-formula>) and (<italic>b</italic>) the conditional force of infection in patch <italic>j</italic> (<inline-formula id="pcbi.1007111.e005"><alternatives><graphic xlink:href="pcbi.1007111.e005.jpg" id="pcbi.1007111.e005g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M5"><mml:msubsup><mml:mi>&#x003b2;</mml:mi><mml:mrow><mml:mi>j</mml:mi></mml:mrow><mml:mtext mathvariant="monospace">eff</mml:mtext></mml:msubsup></mml:math></alternatives></inline-formula>). See <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods for the equations describing the model evolution, details on seeding and vaccination, and the sensitivity analysis of the model.</p><p>Note that the model is described through a system of difference equations, with each time step representing a day. The model is deterministic, and represents the average system trajectory. <xref ref-type="fig" rid="pcbi.1007111.g003">Fig 3</xref> shows an example of the model evolution when simulated with the temporal travel matrix and a hypothetical seeding event in Louisiana.</p><fig id="pcbi.1007111.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g003</object-id><label>Fig 3</label><caption><title>Model evolution.</title><p>Spatio-temporal spread of influenza, for a sample scenario, seeded in Louisiana. Counties where the epidemic emerges by Day 7, 30, 90 or 180 are respectively shaded in red, orange, brown and yellow. We observe that the evolution of influenza spread exhibits both spatially local spread (aided by the commuter flow), and long range transmission events (aided by the domestic airline flow). This is especially evident in the transition between Day 7 to Day 30, where the epidemic originally seeded in southern counties of Louisiana spreads to other neighboring counties, as well as far away counties which have major airport cities (such as Seattle, Chicago, DC).</p></caption><graphic xlink:href="pcbi.1007111.g003"/></fig></sec></sec><sec id="sec016"><title>Spatio-temporal calibration</title><p>Model calibration is the process of estimating parameters of the computational model that can reproduce observed characteristics in the ground truth. In the context of epidemiology, beyond forecasting, calibrated models allow us to perform counterfactual (i.e., what-if) studies, and address resource allocation questions like V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc>. In this section, we will briefly describe our approach and the ground truth used for the two-stage calibration of the national-scale influenza model.</p><p>We begin with the assumption that the ground truth of interest <italic>y</italic> is a noisy version of the simulation model <italic>&#x003b7;</italic>(&#x022c5;) at some unknown input parameter configuration <inline-formula id="pcbi.1007111.e006"><alternatives><graphic xlink:href="pcbi.1007111.e006.jpg" id="pcbi.1007111.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:mover accent="true"><mml:mi>&#x003b8;</mml:mi><mml:mo>^</mml:mo></mml:mover></mml:math></alternatives></inline-formula>. We use a gaussian error model, which are simple and adopted widely for many applications, including epidemics [<xref rid="pcbi.1007111.ref030" ref-type="bibr">30</xref>, <xref rid="pcbi.1007111.ref031" ref-type="bibr">31</xref>]. We adopt importance sampling [<xref rid="pcbi.1007111.ref032" ref-type="bibr">32</xref>] scheme to produce posterior realizations of the calibration parameters. We begin with sampling from an easy-to-sample importance distribution Im(<italic>&#x003b8;</italic>) (say, uniform), and run the simulation model <italic>&#x003b7;</italic> at each of those samples. The importance weights are computed as the ratio of the posterior distribution (proportional to the product of likelihood and prior distribuion) and importance distribution evaluated for each of the samples. The samples along with the normalized weights then constitute an estimate of the posterior distribution.</p><p>Further, it is often useful to factorize the likelihood function, if possible, when the simulation model is required to be calibrated to several different criteria [<xref rid="pcbi.1007111.ref031" ref-type="bibr">31</xref>]. One possible way is to sequentially calibrate the model to different criteria. In addition to simplifying the computation of importance weights, the approach allows user to introduce more samples as needed using the intermediate calibrated parameter space. More details on the statistical framework and the two-stage posterior exploration is provided in <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods.</p><p>Finally, in our case, since we are interested in using a single calibrated model for the optimization study (as against a weighted ensemble provided by the posterior distribution), we consider the Maximum a Posteriori (MAP) estimate i.e., model configuration with highest frequency to be the calibrated model.</p></sec><sec id="sec017"><title>Vaccine allocation optimization</title><p>We now consider the problem of determining the spatial allocation of vaccines across the US to minimize a chosen objective function. In addition to the complexity introduced by non-linear dynamics of the disease model, we also need to account for the temporal constraints imposed by vaccine production and delivery logistics. Formally, the V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> problem involves determining the vaccine allocation vector <italic>X</italic> that minimizes the total attack size given by <italic>f</italic>(<italic>X</italic>). This can be expressed as:
<disp-formula id="pcbi.1007111.e007"><alternatives><graphic xlink:href="pcbi.1007111.e007.jpg" id="pcbi.1007111.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:munder><mml:mtext>minimize</mml:mtext><mml:mi>X</mml:mi></mml:munder></mml:mtd><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mi>f</mml:mi><mml:mo>(</mml:mo><mml:mi>X</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:mtext>subject</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>to</mml:mtext></mml:mrow></mml:mtd><mml:mtd/><mml:mtd columnalign="left"><mml:mrow><mml:munder><mml:mo>&#x02211;</mml:mo><mml:mi>i</mml:mi></mml:munder><mml:msub><mml:mi>X</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>,</mml:mo><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mo>&#x02264;</mml:mo><mml:msub><mml:mi>B</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="4.pt"/><mml:mtext>for</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>all</mml:mtext><mml:mspace width="4.pt"/><mml:mi>t</mml:mi><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
where <italic>B</italic><sub><italic>t</italic></sub> is the total number of vaccines available at time <italic>t</italic>. Our goal in the V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> problem is then determine the amount of vaccine allocated to each patch <italic>i</italic> at time <italic>t</italic>, denoted by <italic>X</italic><sub><italic>i</italic>,<italic>t</italic></sub>.</p><list list-type="bullet"><list-item><p>To reduce the dimensionality of the problem, we focus on allocating vaccines to the states, which are subsequently allocated to the counties proportional to their population. We will also consider the temporal allocation at the level of a weeks. Thus we will denote the allocation to state <italic>s</italic> &#x02208; <italic>S</italic> for week <italic>w</italic> &#x02208; <italic>W</italic> as <italic>X</italic><sub><italic>s</italic>,<italic>w</italic></sub> to improve readability.</p></list-item><list-item><p>A possible objective function <italic>f</italic>(<italic>X</italic>) could be the total national attack size under vaccination schedule <italic>X</italic>, i.e., &#x02211;<sub><italic>i</italic></sub>
<italic>R</italic><sub><italic>i</italic></sub>(<italic>T</italic>), where <italic>T</italic> is the duration of the epidemic, and <italic>R</italic><sub><italic>i</italic></sub>(<italic>T</italic>) denotes the number of individuals in Recovered state in patch <italic>i</italic> at time <italic>T</italic>.</p></list-item><list-item><p><italic>B</italic> is a <italic>W</italic>-dimensional vector, where <italic>B</italic><sub><italic>w</italic></sub> represents the number of vaccines available for week <italic>w</italic>.</p></list-item></list><p>The V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> problem is very challenging, and its exact complexity remains open. A strategy that has been useful in many kinds of intervention design problems is to design a greedy allocation, which selects each decision variable based on the marginal improvement to the objective function. If the problem involves submodular maximization, such a strategy is guaranteed to give a constant factor approximation; see, e.g., [<xref rid="pcbi.1007111.ref022" ref-type="bibr">22</xref>] [<xref rid="pcbi.1007111.ref023" ref-type="bibr">23</xref>]. In contrast, V<sc>acc</sc>I<sc>nt</sc>D<sc>esign</sc> involves a minimization, and the objective functions are neither submodular or supermodular, in general.</p><p>Nevertheless, the greedy strategy is a reasonable approach for designing vaccine allocation strategies, and we study it here with an allocation step size of <italic>L</italic>. The algorithm begins with an initial zero allocation. For each week <italic>w</italic>, the algorithm allocates the next set of <italic>L</italic> vaccines to the state <italic>s</italic> which leads to the maximum reduction in the objective value <italic>f</italic>(<italic>X</italic>). The algorithm is repeated for week <italic>w</italic>, until we exhaust <italic>B</italic><sub><italic>w</italic></sub>, and then proceed to the next week&#x02019;s supply of vaccines. Note that the computation of marginal benefit of allocating <italic>L</italic> additional vaccines to state <italic>s</italic> subject to population constraints, can be computed in parallel.</p><p>As a generalization, we have also included the lookahead duration <italic>d</italic> (in weeks) as an additional parameter. This means that the potential allocations at a greedy stage of week <italic>w</italic> are evaluated by their reduction of attack size at week min(<italic>w</italic> + <italic>d</italic>, <italic>T</italic>) where <italic>T</italic> is the total duration of the epidemic. While this includes the total attack size (full lookahead, when <italic>d</italic> &#x02265; <italic>T</italic>) as a special case, it also allows us to explore the resulting trade-off due to varying forecast horizons. The detailed algorithm is provided in <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods.</p></sec></sec><sec sec-type="results" id="sec018"><title>Results</title><sec id="sec019"><title>Calibration performance</title><sec id="sec020"><title>Calibration criteria</title><p>We calibrate the national influenza model at the level of Health and Human Services (HHS) regions. We use the timing of peak influenza activity across these regions to test the model&#x02019;s ability to reproduce the spatiotemporal variation. To capture the spatial variation of impact, we use the total attack size in each HHS region. Both these calibration criteria are obtained from the Outpatient Influenza-like Illness Surveillance Network (ILINet) data provided by the CDC [<xref rid="pcbi.1007111.ref034" ref-type="bibr">34</xref>]. ILINet reports the weighted percentage of patient visits to healthcare providers for ILI each week and for each HHS region, <monospace>wtILI</monospace>(<italic>h</italic>, <italic>w</italic>).</p><p>While peak timings are straightforward to obtain from ILINet data, regional attack sizes need to be inferred. We use CDC&#x02019;s influenza burden estimates [<xref rid="pcbi.1007111.ref033" ref-type="bibr">33</xref>] with appropriate scaling (accounting for asymptomatic proportion) to obtain the national attack size <monospace>AS</monospace><sub><italic>N</italic></sub>. We then use the normalized cumulative weighted ILI% of an HHS region (<monospace>norm</monospace><sub><italic>h</italic></sub>) to proportionally obtain regional attack sizes.
<disp-formula id="pcbi.1007111.e008"><alternatives><graphic xlink:href="pcbi.1007111.e008.jpg" id="pcbi.1007111.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:mrow><mml:msub><mml:mtext mathvariant="monospace">norm</mml:mtext><mml:mi>h</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mo>&#x02211;</mml:mo><mml:mrow><mml:mi>w</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>W</mml:mi></mml:mrow></mml:msub><mml:mtext mathvariant="monospace">wtILI</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mo>&#x02211;</mml:mo><mml:mover><mml:mrow><mml:mi>w</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>W</mml:mi></mml:mrow><mml:mrow><mml:mi>h</mml:mi><mml:mo>&#x02208;</mml:mo><mml:mi>H</mml:mi></mml:mrow></mml:mover></mml:msub><mml:mtext mathvariant="monospace">wtILI</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mi>h</mml:mi><mml:mo>,</mml:mo><mml:mi>w</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mrow></mml:math></alternatives></disp-formula>
where <italic>W</italic> is the set of weeks of interest (typically from week 40 of a given year to week 20 of the following year, considered to be the influenza season) and <italic>H</italic> is the set of HHS regions. We observe that across seasons <monospace>norm</monospace><sub><italic>h</italic></sub> of HHS regions are quite consistent (as shown in the boxplots of <xref ref-type="fig" rid="pcbi.1007111.g004">Fig 4</xref>), and we used the median value across seasons. For our study, we used the peak timings of 2014-15 influenza season, and a national attack size of 40 million cases.</p><fig id="pcbi.1007111.g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g004</object-id><label>Fig 4</label><caption><p>(a) Normalized cumulative weighted ILI% (<monospace>norm</monospace><sub><italic>h</italic></sub>) for each HHS region, across past influenza seasons. (b) Results of multi-stage calibration. Target attack sizes for each HHS region and peak time are shown relative to the results of the calibration. For each HHS region, green circle represents the ground truth attack size, and the associated green dashed line represents the peak timing. In blue (purple) we show the targets achieved by best model chosen after first (second) stage of calibration. All combinations of attack sizes, peak timing achieved by the particles in the design space are shown in grey.</p></caption><graphic xlink:href="pcbi.1007111.g004"/></fig></sec><sec id="sec021"><title>Calibrated parameters</title><p>The following is the list of simulation parameters (<italic>&#x003b8;</italic>) in the national influenza model.
<disp-formula id="pcbi.1007111.e009"><alternatives><graphic xlink:href="pcbi.1007111.e009.jpg" id="pcbi.1007111.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>500</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>s</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mtext>Number</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>of</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>initial</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>seeds</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>in</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>county</mml:mtext><mml:mspace width="4pt"/><mml:mi>k</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:mn>2000</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mn>7</mml:mn><mml:mtext>levels</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mi>k</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mtext>Seeding</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>timing</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>in</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>county</mml:mtext><mml:mspace width="4pt"/><mml:mi>k</mml:mi></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:mn>28</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mn>29</mml:mn><mml:mspace width="4.pt"/><mml:mtext>levels</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>4</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>&#x003b2;</mml:mi><mml:mo>=</mml:mo><mml:mtext>Transmissibility</mml:mtext></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>9</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>2</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mtext>eff</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mtext>Vaccination</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>efficacy</mml:mtext></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>14</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:msub><mml:mi>c</mml:mi><mml:mtext>del</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mtext>Vaccination</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>delay</mml:mtext></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mn>28</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mn>15</mml:mn><mml:mspace width="4.pt"/><mml:mtext>levels</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mn>0</mml:mn><mml:mo>&#x02264;</mml:mo></mml:mrow></mml:mtd><mml:mtd><mml:mrow><mml:msub><mml:mi>A</mml:mi><mml:mi>w</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mtext>Stay</mml:mtext><mml:mspace width="4.pt"/><mml:mtext>duration</mml:mtext></mml:mrow></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>&#x02264;</mml:mo><mml:mn>5</mml:mn><mml:mo>,</mml:mo><mml:mspace width="0.277778em"/><mml:mspace width="0.277778em"/><mml:mn>6</mml:mn><mml:mspace width="4.pt"/><mml:mtext>levels</mml:mtext></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mrow/></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula></p><p>For seeding the influenza model, we used data from CDC ILI Activity Level Indicator [<xref rid="pcbi.1007111.ref035" ref-type="bibr">35</xref>] for the 2014-15 season. We chose to seed in Louisiana and Alabama, the two earliest states to reach High activity level in the season. Within these states, we chose to seed in the most populous counties (Lafourche parish, LA and Jefferson county, AL) respectively. The seeding policy is consistent with the finding that most influenza seasons likely start from the Southern US [<xref rid="pcbi.1007111.ref024" ref-type="bibr">24</xref>]. Given the seeding in two counties, we now have 8 parameters to be calibrated <italic>&#x003b8;</italic> = (<italic>s</italic><sub>1</sub>, <italic>s</italic><sub>2</sub>, <italic>t</italic><sub>1</sub>, <italic>t</italic><sub>2</sub>, <italic>&#x003b2;</italic>, <italic>vac</italic><sub>eff</sub>, <italic>vac</italic><sub>del</sub>, <italic>A</italic><sub><italic>w</italic></sub>). Note that the seeding time is time since the start of the simulation. We fix the remaining parameters of the disease model (such as <italic>&#x003b1;</italic>, <italic>&#x003b3;</italic>) based on literature. In our study, <italic>&#x003b1;</italic> = 0.67, <italic>&#x003b3;</italic> = 0.4 and correspond to mean incubation period of 1.5 days and mean infectious period of 2.5 days [<xref rid="pcbi.1007111.ref014" ref-type="bibr">14</xref>].</p><p>We begin with an initial set of <italic>m</italic> uniformly random parameter configurations according to (<xref ref-type="disp-formula" rid="pcbi.1007111.e009">1</xref>). Based on initial runs, we choose to work with <italic>m</italic> = 1000. Full simulations are carried out at these 1000 configurations to obtain simulated regional attack sizes and peak timings. We then perform the two-stage calibration procedure described earlier, to obtain a MAP estimate of the best parameter configuration. For the gaussian likelihood (see <xref ref-type="supplementary-material" rid="pcbi.1007111.s001">S1 Appendix</xref>. Additional methods on Calibration methodology), we defined independent errors with a standard deviation of 20% around the calibration criteria [<xref rid="pcbi.1007111.ref030" ref-type="bibr">30</xref>]. While varying the standard deviation may affect the posterior distribution, it is to be noted that the MAP estimator remains unaffected.</p><p>After the first stage of calibration (i.e. regional attack sizes), the MAP estimate <inline-formula id="pcbi.1007111.e010"><alternatives><graphic xlink:href="pcbi.1007111.e010.jpg" id="pcbi.1007111.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:mrow><mml:msubsup><mml:mi>&#x003b8;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x022c6;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>1000</mml:mn><mml:mo>,</mml:mo><mml:mn>1250</mml:mn><mml:mo>,</mml:mo><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mn>5</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>43</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>53</mml:mn><mml:mo>,</mml:mo><mml:mn>23</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. After the second stage of calibration (i.e.,regional peak timing), we get <inline-formula id="pcbi.1007111.e011"><alternatives><graphic xlink:href="pcbi.1007111.e011.jpg" id="pcbi.1007111.e011g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M11"><mml:mrow><mml:msubsup><mml:mi>&#x003b8;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x022c6;</mml:mo></mml:msubsup><mml:mo>=</mml:mo><mml:mrow><mml:mo>(</mml:mo><mml:mn>2000</mml:mn><mml:mo>,</mml:mo><mml:mn>1500</mml:mn><mml:mo>,</mml:mo><mml:mn>18</mml:mn><mml:mo>,</mml:mo><mml:mn>21</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>59</mml:mn><mml:mo>,</mml:mo><mml:mn>0</mml:mn><mml:mo>.</mml:mo><mml:mn>56</mml:mn><mml:mo>,</mml:mo><mml:mn>22</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:math></alternatives></inline-formula>. <xref ref-type="fig" rid="pcbi.1007111.g004">Fig 4</xref> shows the results of multi-stage calibration, with the green, blue and purple circles respectively showing the calibration criteria, simulated output with <inline-formula id="pcbi.1007111.e012"><alternatives><graphic xlink:href="pcbi.1007111.e012.jpg" id="pcbi.1007111.e012g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M12"><mml:msubsup><mml:mi>&#x003b8;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x022c6;</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula> and simulated output with <inline-formula id="pcbi.1007111.e013"><alternatives><graphic xlink:href="pcbi.1007111.e013.jpg" id="pcbi.1007111.e013g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M13"><mml:msubsup><mml:mi>&#x003b8;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x022c6;</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula>. We use <inline-formula id="pcbi.1007111.e014"><alternatives><graphic xlink:href="pcbi.1007111.e014.jpg" id="pcbi.1007111.e014g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M14"><mml:msubsup><mml:mi>&#x003b8;</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#x022c6;</mml:mo></mml:msubsup></mml:math></alternatives></inline-formula> as the calibrated parameter for the vaccine allocation study. We note that we are able to calibrate within 14% of the national attack size. The calibrated model is also within 24% on average for HHS region level attack sizes and 1.5 weeks (11 days) for the respective peak timings.</p></sec></sec><sec id="sec022"><title>Optimization study scenarios</title><p>For the current study, we begin with the disease model calibrated to the 2014-15 influenza season. Given the best fit model <italic>M</italic><sub><italic>&#x003b8;</italic><sup>&#x022c6;</sup></sub>, we define the optimization study scenarios as follows: A scenario is defined by a (<italic>v</italic>, <italic>E</italic>) tuple and is derived by setting the vaccination efficacy to <italic>v</italic> in model <italic>M</italic><sub><italic>&#x003b8;</italic><sup>&#x022c6;</sup></sub> and calibrating the transmissibility <italic>&#x003b2;</italic> to achieve national attack size of <italic>E</italic> under pro rata vaccine allocation.</p><p>We do this to simulate multiple seasons that spread spatially like the 2014-15 season, but vary in their severity (captured by the national attack size <italic>E</italic>) and the efficacy of seasonal vaccine (captured by <italic>v</italic>). In our study setting, we construct 12 scenarios, where <italic>v</italic> takes values in {0.2, 0.35, 0.5} and <italic>E</italic> takes values in {40, 61, 73, 86} where the values are in millions of cases, corresponding to different severity levels based on past seasons of seasonal influenza. Thus for each target attack size <italic>E</italic>, we have three scenarios, in which <italic>E</italic> is achieved by assigning vaccines at <italic>v</italic> efficacy.</p><p>In our study (restricted to contiguous US, including DC), the number of states <italic>S</italic> = 49. Also, we set the number of weeks <italic>W</italic> = 40, roughly the period from September to May corresponding to the influenza season. Therefore, the allocation profile <italic>X</italic> has 1960 spatio-temporal dimensions. The temporal constraint <italic>B</italic> is based on historical vaccine uptake schedue available from CDC FluVaxView [<xref rid="pcbi.1007111.ref036" ref-type="bibr">36</xref>]. CDC FluVaxView provides monthly coverage estimates nationally for the past influenza seasons. We scaled it by the national population to get a vaccine uptake schedule and converted it to the temporal constraint <italic>B</italic>. Note that CDC also provides the vaccine supply and distribution schedule [<xref rid="pcbi.1007111.ref037" ref-type="bibr">37</xref>], however, we noticed a considerable delay between the supply and uptake schedules, so we chose to use the uptake schedule to reflect ground reality.</p><sec id="sec023"><title>Effect of vaccine efficacy</title><p><xref ref-type="fig" rid="pcbi.1007111.g005">Fig 5</xref> shows the attack size under optimized allocation under a 10 week lookahead policy. In the least severe scenario (40 million cases), with the best vaccine efficacy (0.5), we are able to reduce the national attack size by up to 17%. On the other extreme, with 80 million cases and 0.2 vaccine efficacy, the allocation helps, but only minimally (2%). Another thing to note is that for a fixed attack size scenario, with increased vaccine efficacy, the benefit of optimized allocation increases. This makes sense, since this translates to more effective vaccines being moved around.</p><fig id="pcbi.1007111.g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g005</object-id><label>Fig 5</label><caption><title>Episizes achieved by optimized allocation for different baseline episizes and vaccine efficacies.</title></caption><graphic xlink:href="pcbi.1007111.g005"/></fig></sec><sec id="sec024"><title>Spatio-temporal allocation of vaccines</title><p>Note that the algorithm outputs an allocation schedule, where for each week, each state is allocated <italic>X</italic><sub><italic>s</italic>,<italic>w</italic></sub> units of vaccines. This can be visualized using a 2-D heat-map as shown in <xref ref-type="fig" rid="pcbi.1007111.g006">Fig 6</xref>. It is useful to remember that all simulations are initialized in Louisiana and Alabama. <xref ref-type="fig" rid="pcbi.1007111.g006">Fig 6</xref> shows the allocation by the 10 week lookahead policy with vaccine efficacy of 0.5. We observe that the optimized allocation begins allocating to Louisiana (state code LA), followed by its neighbors Alabama (AL), and Mississippi (MS). This is followed by larger states around Louisiana such as Texas, Georgia, and Florida. This is very different from a pro-rata allocation scheme (distributing the vaccines for each week proportional to state populations). This strategy also resembles a ring-vaccination (in social contact networks), applied spatially to regions around the origin of the epidemic. Further, even though we prioritize some of the states early in the season, the final vaccine allocation for each state is close to its pro-rata quota. As shown in <xref ref-type="fig" rid="pcbi.1007111.g007">Fig 7</xref>, most states receive their fair-share of vaccines.</p><fig id="pcbi.1007111.g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g006</object-id><label>Fig 6</label><caption><title>Weekly allocation of vaccines across states for the optimized allocation with 10 week lookahed, vaccine efficacy of 0.5 and baseline episize of 40M.</title></caption><graphic xlink:href="pcbi.1007111.g006"/></fig><fig id="pcbi.1007111.g007" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g007</object-id><label>Fig 7</label><caption><title>Population normalized total allocation of vaccines per state under the optimized schedule.</title><p>A value of 1.0 indicates that the state received exactly the same amount of vaccines it would have received under the pro-rata schedule. Values greater (less) than 1.0 correspond to more (fewer) vaccines allocated under the optimized schedule than the pro-rata schedule.</p></caption><graphic xlink:href="pcbi.1007111.g007"/></fig></sec><sec id="sec025"><title>Sensitivity to hyperparameters</title><p>We also tested the sensitivity of greedy algorithm performance to the hyperparameters of the algorithm, namely lookahead duration <italic>d</italic> and the vaccine allocation stepsize <italic>L</italic>. We tested the sensitivity on the best fit configuration for 2014, with total national attack size of 34 million. We observe from <xref ref-type="fig" rid="pcbi.1007111.g008">Fig 8</xref> that the solution quality is pretty stable across allocation step size <italic>L</italic>, with marginal improvement for lower <italic>L</italic> (although the runtime for <italic>L</italic> = 100, 000 step size would be roughly 5 times as longer as that for <italic>L</italic> = 500, 000).</p><fig id="pcbi.1007111.g008" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1007111.g008</object-id><label>Fig 8</label><caption><title>Effect of hyperparameters (lookahead duration and allocation stepsize) on algorithm performance.</title></caption><graphic xlink:href="pcbi.1007111.g008"/></fig><p>We also found that a medium lookahead policy (10 weeks) performed better than a short-term or full lookahead policy. This implies that allowing the algorithm to target the reduction of attack size a couple of months into the future, leads to improved performance in the final attack size. Short lookahead duration (5 weeks) does not perform well, because the lookahead is almost comparable to the delay for the vaccine to take effect. For longer lookahead, the algorithm allocates vaccines to states farther from the current epidemic activity to have the most impact on the total attack size at the end of the simulation. This, however, may not limit the spatial spread of the disease per se, and hence may be sub-optimal. As we can see, the medium lookahead policy, through its ring-vaccination style approach, ensures that the disease is curbed near its origin, thus leading to greater overall reduction in the attack size.</p></sec></sec></sec><sec sec-type="conclusions" id="sec026"><title>Discussion</title><p>Current policies for vaccine interventions are designed based on a host of social and political issues, and tend to be fairly simplistic. For instance, Department of Health and Human Services (HHS) directives for targeting pandemic vaccines are based on age group [<xref rid="pcbi.1007111.ref005" ref-type="bibr">5</xref>], and the allocation of the national vaccine supply and other resources is typically done proportional to the state population. There has been a lot of interest in developing more effective interventions, e.g., [<xref rid="pcbi.1007111.ref002" ref-type="bibr">2</xref>] [<xref rid="pcbi.1007111.ref004" ref-type="bibr">4</xref>] [<xref rid="pcbi.1007111.ref025" ref-type="bibr">25</xref>] [<xref rid="pcbi.1007111.ref026" ref-type="bibr">26</xref>]. For instance, Medlock et al. [<xref rid="pcbi.1007111.ref002" ref-type="bibr">2</xref>] developed an optimal vaccination strategy for the H1N1 outbreak; their model showed a prioritization for a different age group than the ones recommended by CDC directives. All prior methods are restricted to simple models, and only focus on non-temporal interventions in which the allocation is done ahead of time. In reality, vaccine supply varies over time, and the real problem involves finding an allocation that respects the supply constraints and optimizes the epidemic outcomes.</p><p>Our current model can be extended in several ways. Firstly, the model calibration process can be refined to match more detailed trajectories of influenza spread, like the ILI % time series, or the in-season burden estimates being produced by CDC starting 2018-19 season [<xref rid="pcbi.1007111.ref033" ref-type="bibr">33</xref>]. Such approaches can then be used to do real-time forecasting and provide vaccine allocation recommendations for an ongoing influenza season. Further, instead of selecting the MAP model for vaccination study, one could use an ensemble of calibrated models based on the posterior distribution, thus being able to quantify uncertainty in the vaccine allocation policy&#x02019;s effectiveness. Another aspect of the real-world dynamics currently not being captured in our model is that of residual immunity. The national influenza model can be improved by taking into account the co-circulating and dominant influenza strains, as well as the strains present in the recommended vaccine for the season. Note that while improving over pro-rata allocation, greedy algorithm, even with the lookahead duration, may lead to sub-optimal policies. One can develop algorithms that earmark resources for regions with high spreading capacity, thus potentially improving the effectiveness of vaccine allocation.</p><p>Finally, the logistics of the supply of medical resources, such as medicines, medical equipment (e.g., ventilators), and medical staff is also very complex. The health infrastructure is generally optimized for typical demand for such resources, and any surge, as would happen during a pandemic outbreak, would place a severe strain on hospitals. Ajao et al. [<xref rid="pcbi.1007111.ref027" ref-type="bibr">27</xref>] show that over 50,000 ventilators might be needed in the event of a national influenza pandemic outbreak. Since local and state health systems are usually unprepared for such a surge in demand, the Office of the Assistance Secretary for Preparedness and Response (ASPR) maintains a stockpile of mechanical ventilators in strategic locations [<xref rid="pcbi.1007111.ref038" ref-type="bibr">38</xref>], which can be deployed during an emergency. While existing efforts partially address the question of optimizing stockpile redistribution [<xref rid="pcbi.1007111.ref028" ref-type="bibr">28</xref>], a mechanistic model like the one developed in this paper will help design better national-scale studies for pandemic preparedness exercises, and develop strategies for allocation of vaccines and other resources during such emergencies.</p><p>In conclusion, we have presented a national level seasonal influenza model, based on short-range and long-range mobility datasets, and used it to optimize the spatio-temporal allocation of vaccines. For the scenario under consideration, we find that the national attack size can be reduced by up to 17% by allocating the early vaccines to regions around the origin of the epidemic. Most states still end up with close to their overall pro-rata quota of vaccines, however, these findings demonstrate that shifting when and where these vaccines are administered has a sizable impact on the national attack size. Achieving these optimal outcomes would require better surveillance and the ability to accelerate vaccine uptake at will, which presents multiple challenges. However, the study shows there is ample room for improvement and this framework provides means for developing a play-book for epidemic containment.</p></sec><sec sec-type="supplementary-material" id="sec027"><title>Supporting information</title><supplementary-material content-type="local-data" id="pcbi.1007111.s001"><label>S1 Appendix</label><caption><title>Additional methods.</title><p>Additional technical details pertaining to the disease model, calibration framework and optimization algorithm are provided.</p><p>(PDF)</p></caption><media xlink:href="pcbi.1007111.s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We thank our external collaborators and members of the Network Systems Science &#x00026; Advanced Computing Division for their suggestions and comments.</p></ack><ref-list><title>References</title><ref id="pcbi.1007111.ref001"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Christopher</surname><given-names>Dye</given-names></name>. <article-title>After 2015: Infectious diseases in a new era of health and development</article-title>. <source>Philosophical Transactions of the Royal Society B: Biological Sciences</source>. <year>2014</year>;<volume>369</volume>(<issue>1645</issue>):<fpage>20130426</fpage>
<pub-id pub-id-type="doi">10.1098/rstb.2013.0426</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref002"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Medlock</surname><given-names>J</given-names></name>, <name><surname>Galvani</surname><given-names>AP</given-names></name>. <article-title>Optimizing influenza vaccine distribution</article-title>. <source>Science</source>. <year>2009</year>;<volume>325</volume>(<issue>5948</issue>):<fpage>1705</fpage>&#x02013;<lpage>1708</lpage>. <pub-id pub-id-type="doi">10.1126/science.1175570</pub-id>
<?supplied-pmid 19696313?><pub-id pub-id-type="pmid">19696313</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref003"><label>3</label><mixed-citation publication-type="other">Estimated Influenza Illnesses, Medical visits, and Hospitalizations Averted by Vaccination <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/burden-averted/index.htm">https://www.cdc.gov/flu/about/burden-averted/index.htm</ext-link> (accessed 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref004"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Eubank</surname><given-names>S</given-names></name>, <name><surname>Guclu</surname><given-names>H</given-names></name>, <name><surname>Kumar</surname><given-names>VA</given-names></name>, <name><surname>Marathe</surname><given-names>MV</given-names></name>, <name><surname>Srinivasan</surname><given-names>A</given-names></name>, <name><surname>Toroczkai</surname><given-names>Z</given-names></name>, <etal>et al</etal>
<article-title>Modeling disease outbreaks in realistic urban social networks</article-title>. <source>Nature</source>. <year>2004</year>;<volume>429</volume>(<issue>6988</issue>):<fpage>180</fpage>
<pub-id pub-id-type="doi">10.1038/nature02541</pub-id>
<?supplied-pmid 15141212?><pub-id pub-id-type="pmid">15141212</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref005"><label>5</label><mixed-citation publication-type="other">U.S. Department of Health and Human Services, Guidance on allocating and targeting pandemic influenza vaccine <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/pandemic-resources/pdf/2018-Influenza-Guidance.pdf">https://www.cdc.gov/flu/pandemic-resources/pdf/2018-Influenza-Guidance.pdf</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref006"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Sah</surname><given-names>P</given-names></name>, <name><surname>Medlock</surname><given-names>J</given-names></name>, <name><surname>Fitzpatrick</surname><given-names>MC</given-names></name>, <name><surname>Singer</surname><given-names>BH</given-names></name>, <name><surname>Galvani</surname><given-names>AP</given-names></name>. <article-title>Optimizing the impact of low-efficacy influenza vaccines</article-title>. <source>Proceedings of the National Academy of Sciences</source>. <year>2018</year>
<pub-id pub-id-type="doi">10.1073/pnas.1802479115</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref007"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Viboud</surname><given-names>C</given-names></name>, <name><surname>Bj&#x000f8;rnstad</surname><given-names>ON</given-names></name>, <name><surname>Smith</surname><given-names>DL</given-names></name>, <name><surname>Simonsen</surname><given-names>L</given-names></name>, <name><surname>Miller</surname><given-names>MA</given-names></name>, <name><surname>Grenfell</surname><given-names>BT</given-names></name>. <article-title>Synchrony, waves, and spatial hierarchies in the spread of influenza</article-title>. <source>Science</source>. <year>2006</year>;<volume>312</volume>(<issue>5772</issue>):<fpage>447</fpage>&#x02013;<lpage>451</lpage>. <pub-id pub-id-type="doi">10.1126/science.1125237</pub-id>
<?supplied-pmid 16574822?><pub-id pub-id-type="pmid">16574822</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref008"><label>8</label><mixed-citation publication-type="book">
<name><surname>Larson</surname><given-names>RC</given-names></name>, <name><surname>Teytelman</surname><given-names>A</given-names></name>, <name><surname>Finkelstein</surname><given-names>S</given-names></name>. <chapter-title>Operations Research and Homeland Security: Overview and Case Study of Pandemic Influenza</chapter-title> In: <source>Handbook of Operations Research for Homeland Security</source>. <publisher-name>Springer</publisher-name>; <year>2013</year> p. <fpage>25</fpage>&#x02013;<lpage>43</lpage>.</mixed-citation></ref><ref id="pcbi.1007111.ref009"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Colizza</surname><given-names>V</given-names></name>, <name><surname>Barrat</surname><given-names>A</given-names></name>, <name><surname>Barth&#x000e9;lemy</surname><given-names>M</given-names></name>, <name><surname>Vespignani</surname><given-names>A</given-names></name>. <article-title>The role of the airline transportation network in the prediction and predictability of global epidemics</article-title>. <source>Proceedings of the National Academy of Sciences of the United States of America</source>. <year>2006</year>;<volume>103</volume>(<issue>7</issue>):<fpage>2015</fpage>&#x02013;<lpage>2020</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0510525103</pub-id>
<?supplied-pmid 16461461?><pub-id pub-id-type="pmid">16461461</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref010"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Ren</surname><given-names>Yihui</given-names></name>, <name><surname>M&#x000e1;ria</surname><given-names>Ercsey-Ravasz</given-names></name>, <name><surname>Wang</surname><given-names>Pu</given-names></name>, <name><surname>Gonz&#x000e1;lez</surname><given-names>Marta C.</given-names></name>, and <name><surname>Toroczkai</surname><given-names>Zolt&#x000e1;n</given-names></name>. <article-title>Predicting commuter flows in spatial networks using a radiation model based on temporal ranges</article-title>. <source>Nature communications</source>
<volume>5</volume> (<year>2014</year>): <fpage>5347</fpage>
<pub-id pub-id-type="doi">10.1038/ncomms6347</pub-id>
<?supplied-pmid 25373437?><pub-id pub-id-type="pmid">25373437</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref011"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Marathe</surname><given-names>M</given-names></name>, <name><surname>Vullikanti</surname><given-names>AKS</given-names></name>. <article-title>Computational epidemiology</article-title>. <source>Communications of the ACM</source>. <year>2013</year>;<volume>56</volume>(<issue>7</issue>):<fpage>88</fpage>&#x02013;<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1145/2483852.2483871</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref012"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Dimitrov</surname><given-names>NB</given-names></name>, <name><surname>Meyers</surname><given-names>LA</given-names></name>. <article-title>Mathematical approaches to infectious disease prediction and control</article-title>. <source>INFORMS tutorials in operations research</source>. <year>2010</year>;<volume>7</volume>:<fpage>1</fpage>&#x02013;<lpage>25</lpage>.</mixed-citation></ref><ref id="pcbi.1007111.ref013"><label>13</label><mixed-citation publication-type="journal">
<name><surname>Longini</surname><given-names>IM</given-names></name>, <name><surname>Nizam</surname><given-names>A</given-names></name>, <name><surname>Xu</surname><given-names>S</given-names></name>, <name><surname>Ungchusak</surname><given-names>K</given-names></name>, <name><surname>Hanshaoworakul</surname><given-names>W</given-names></name>, <name><surname>Cummings</surname><given-names>DA</given-names></name>, <etal>et al</etal>
<article-title>Containing pandemic influenza at the source</article-title>. <source>Science</source>. <year>2005</year>;<volume>309</volume>(<issue>5737</issue>):<fpage>1083</fpage>&#x02013;<lpage>1087</lpage>. <pub-id pub-id-type="doi">10.1126/science.1115717</pub-id>
<?supplied-pmid 16079251?><pub-id pub-id-type="pmid">16079251</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref014"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Cori</surname><given-names>A.</given-names></name>, <name><surname>Valleron</surname><given-names>A. J.</given-names></name>, <name><surname>Carrat</surname><given-names>F.</given-names></name>, <name><surname>Scalia Tomba</surname><given-names>G.</given-names></name>, <name><surname>Thomas</surname><given-names>G.</given-names></name>, and <name><surname>Bo&#x000eb;lle</surname><given-names>P. Y</given-names></name>. <article-title>Estimating influenza latency and infectious period durations using viral excretion data</article-title>. <source>Epidemics</source>
<volume>4</volume>,<issue>no. 3</issue> (<year>2012</year>): <fpage>132</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.epidem.2012.06.001</pub-id>
<?supplied-pmid 22939310?><pub-id pub-id-type="pmid">22939310</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref015"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Ferguson</surname><given-names>NM</given-names></name>, <name><surname>Cummings</surname><given-names>DA</given-names></name>, <name><surname>Cauchemez</surname><given-names>S</given-names></name>, <name><surname>Fraser</surname><given-names>C</given-names></name>, <name><surname>Riley</surname><given-names>S</given-names></name>, <name><surname>Meeyai</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Strategies for containing an emerging influenza pandemic in Southeast Asia</article-title>. <source>Nature</source>. <year>2005</year>;<volume>437</volume>(<issue>7056</issue>):<fpage>209</fpage>
<pub-id pub-id-type="doi">10.1038/nature04017</pub-id>
<?supplied-pmid 16079797?><pub-id pub-id-type="pmid">16079797</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref016"><label>16</label><mixed-citation publication-type="journal">
<name><surname>Tuite</surname><given-names>AR</given-names></name>, <name><surname>Fisman</surname><given-names>DN</given-names></name>, <name><surname>Kwong</surname><given-names>JC</given-names></name>, <name><surname>Greer</surname><given-names>AL</given-names></name>. <article-title>Optimal pandemic influenza vaccine allocation strategies for the Canadian population</article-title>. <source>PloS one</source>. <year>2010</year>;<volume>5</volume>(<issue>5</issue>):<fpage>e10520</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0010520</pub-id>
<?supplied-pmid 20463898?><pub-id pub-id-type="pmid">20463898</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref017"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Balcan</surname><given-names>D</given-names></name>, <name><surname>Gon&#x000e7;alves</surname><given-names>B</given-names></name>, <name><surname>Hu</surname><given-names>H</given-names></name>, <name><surname>Ramasco</surname><given-names>JJ</given-names></name>, <name><surname>Colizza</surname><given-names>V</given-names></name>, <name><surname>Vespignani</surname><given-names>A</given-names></name>. <article-title>Modeling the spatial spread of infectious diseases: The GLobal Epidemic and Mobility computational model</article-title>. <source>Journal of computational science</source>. <year>2010</year>;<volume>1</volume>(<issue>3</issue>):<fpage>132</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.jocs.2010.07.002</pub-id>
<?supplied-pmid 21415939?><pub-id pub-id-type="pmid">21415939</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref018"><label>18</label><mixed-citation publication-type="other">Venkatramanan S, Chen J, Gupta S, Lewis B, Marathe M, Mortveit H, et al. Spatio-temporal optimization of seasonal vaccination using a metapopulation model of influenza. In: Healthcare Informatics (ICHI), 2017 IEEE International Conference on. IEEE; 2017. p. 134&#x02013;143.</mixed-citation></ref><ref id="pcbi.1007111.ref019"><label>19</label><mixed-citation publication-type="other">American Community Survey, US Census Bureau. <ext-link ext-link-type="uri" xlink:href="https://www.census.gov/programs-surveys/acs/">https://www.census.gov/programs-surveys/acs/</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref020"><label>20</label><mixed-citation publication-type="other">Airline Information for Download, Bureau of Transportation Statistics. <ext-link ext-link-type="uri" xlink:href="https://www.bts.gov/topics/airlines-and-airports/airline-information-download">https://www.bts.gov/topics/airlines-and-airports/airline-information-download</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref021"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Bichara</surname><given-names>D</given-names></name>, <name><surname>Kang</surname><given-names>Y</given-names></name>, <name><surname>Castillo-Chavez</surname><given-names>C</given-names></name>, <name><surname>Horan</surname><given-names>R</given-names></name>, <name><surname>Perrings</surname><given-names>C</given-names></name>. <article-title>SIS and SIR epidemic models under virtual dispersal</article-title>. <source>Bulletin of mathematical biology</source>. <year>2015</year>;<volume>77</volume>(<issue>11</issue>):<fpage>2004</fpage>&#x02013;<lpage>2034</lpage>. <pub-id pub-id-type="doi">10.1007/s11538-015-0113-5</pub-id>
<?supplied-pmid 26489419?><pub-id pub-id-type="pmid">26489419</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref022"><label>22</label><mixed-citation publication-type="other">Zhang Y, Adiga A, Vullikanti A, Prakash BA. Controlling propagation at group scale on networks. In: Data Mining (ICDM), 2015 IEEE International Conference on. IEEE; 2015. p. 619&#x02013;628.</mixed-citation></ref><ref id="pcbi.1007111.ref023"><label>23</label><mixed-citation publication-type="other">Saha S, Adiga A, Prakash BA, Vullikanti AKS. Approximation algorithms for reducing the spectral radius to control epidemic spread. In: Proceedings of the 2015 SIAM International Conference on Data Mining. SIAM; 2015. p. 568&#x02013;576.</mixed-citation></ref><ref id="pcbi.1007111.ref024"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Charu</surname><given-names>V</given-names></name>, <name><surname>Zeger</surname><given-names>S</given-names></name>, <name><surname>Gog</surname><given-names>J</given-names></name>, <name><surname>Bj&#x000f8;rnstad</surname><given-names>ON</given-names></name>, <name><surname>Kissler</surname><given-names>S</given-names></name>, <name><surname>Simonsen</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Human mobility and the spatial transmission of influenza in the United States</article-title>. <source>PLoS computational biology</source>. <year>2017</year>;<volume>13</volume>(<issue>2</issue>):<fpage>e1005382</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pcbi.1005382</pub-id>
<?supplied-pmid 28187123?><pub-id pub-id-type="pmid">28187123</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref025"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Shim</surname><given-names>E</given-names></name>. <article-title>Optimal strategies of social distancing and vaccination against seasonal influenza</article-title>. <source>Mathematical Biosciences &#x00026; Engineering</source>. <year>2013</year>;<volume>10</volume>(<issue>5/6</issue>):<fpage>1615</fpage>&#x02013;<lpage>1634</lpage>. <pub-id pub-id-type="doi">10.3934/mbe.2013.10.1615</pub-id><pub-id pub-id-type="pmid">24245639</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref026"><label>26</label><mixed-citation publication-type="other">Prakash BA, Adamic L, Iwashyna T, Tong H, Faloutsos C. Fractional immunization in networks. In: Proceedings of the 2013 SIAM International Conference on Data Mining. SIAM; 2013. p. 659&#x02013;667.</mixed-citation></ref><ref id="pcbi.1007111.ref027"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Ajao</surname><given-names>A</given-names></name>, <name><surname>Nystrom</surname><given-names>SV</given-names></name>, <name><surname>Koonin</surname><given-names>LM</given-names></name>, <name><surname>Patel</surname><given-names>A</given-names></name>, <name><surname>Howell</surname><given-names>DR</given-names></name>, <name><surname>Baccam</surname><given-names>P</given-names></name>, <etal>et al</etal>
<article-title>Assessing the capacity of the US health care system to use additional mechanical ventilators during a large-scale public health emergency</article-title>. <source>Disaster medicine and public health preparedness</source>. <year>2015</year>;<volume>9</volume>(<issue>6</issue>):<fpage>634</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1017/dmp.2015.105</pub-id>
<?supplied-pmid 26450633?><pub-id pub-id-type="pmid">26450633</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref028"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Huang</surname><given-names>HC</given-names></name>, <name><surname>Araz</surname><given-names>OM</given-names></name>, <name><surname>Morton</surname><given-names>DP</given-names></name>, <name><surname>Johnson</surname><given-names>GP</given-names></name>, <name><surname>Damien</surname><given-names>P</given-names></name>, <name><surname>Clements</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Stockpiling ventilators for influenza pandemics</article-title>. <source>Emerging infectious diseases</source>. <year>2017</year>;<volume>23</volume>(<issue>6</issue>):<fpage>914</fpage>
<pub-id pub-id-type="doi">10.3201/eid2306.161417</pub-id>
<?supplied-pmid 28518041?><pub-id pub-id-type="pmid">28518041</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref029"><label>29</label><mixed-citation publication-type="other">PatchSim code and data for sample US simulation. <ext-link ext-link-type="uri" xlink:href="https://github.com/srinivvenkat/PatchSim">https://github.com/srinivvenkat/PatchSim</ext-link>.</mixed-citation></ref><ref id="pcbi.1007111.ref030"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Fadikar</surname><given-names>A</given-names></name>, <name><surname>Higdon</surname><given-names>D</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Lewis</surname><given-names>B</given-names></name>, <name><surname>Venkatramanan</surname><given-names>S</given-names></name>, <name><surname>Marathe</surname><given-names>M</given-names></name>. <article-title>Calibrating a Stochastic, Agent-Based Model Using Quantile-Based Emulation</article-title>. <source>SIAM/ASA Journal on Uncertainty Quantification</source>. <year>2018</year>;<volume>6</volume>(<issue>4</issue>). p. <fpage>1685</fpage>&#x02013;<lpage>1706</lpage>. <pub-id pub-id-type="doi">10.1137/17M1161233</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref031"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Higdon</surname><given-names>D</given-names></name>, <name><surname>Gattiker</surname><given-names>J</given-names></name>, <name><surname>Lawrence</surname><given-names>E</given-names></name>, <name><surname>Jackson</surname><given-names>C</given-names></name>, <name><surname>Tobis</surname><given-names>M</given-names></name>, <name><surname>Pratola</surname><given-names>M</given-names></name>, <name><surname>Habib</surname><given-names>S</given-names></name>, <name><surname>Heitmann</surname><given-names>K</given-names></name>, <name><surname>Price</surname><given-names>S</given-names></name>. <article-title>Computer model calibration using the ensemble kalman filter</article-title>. <source>Technometrics</source>. <year>2013</year>;<volume>55</volume>(<issue>4</issue>). p. <fpage>488</fpage>&#x02013;<lpage>500</lpage>. <pub-id pub-id-type="doi">10.1080/00401706.2013.842936</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref032"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Doucet</surname><given-names>A.</given-names></name>, <name><surname>Godsill</surname><given-names>S.</given-names></name>, <name><surname>Andrieu</surname><given-names>C</given-names></name>. <article-title>On sequential Monte Carlo sampling methods for Bayesian filtering</article-title>. <source>Statistics and computing</source>. <volume>10</volume>(<issue>3</issue>), <fpage>197</fpage>&#x02013;<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1023/A:1008935410038</pub-id></mixed-citation></ref><ref id="pcbi.1007111.ref033"><label>33</label><mixed-citation publication-type="other">Disease Burden of Influenza <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/burden/index.html">https://www.cdc.gov/flu/about/burden/index.html</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref034"><label>34</label><mixed-citation publication-type="other">National, Regional, and State Level Outpatient Illness and Viral Surveillance, CDC. <ext-link ext-link-type="uri" xlink:href="https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html">https://gis.cdc.gov/grasp/fluview/fluportaldashboard.html</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref035"><label>35</label><mixed-citation publication-type="other">Weekly Influenza Surveillance Report Prepared by the Influenza Division, CDC. <ext-link ext-link-type="uri" xlink:href="https://gis.cdc.gov/grasp/fluview/main.html">https://gis.cdc.gov/grasp/fluview/main.html</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref036"><label>36</label><mixed-citation publication-type="other">FluVaxView: Influenza Vaccination Coverage, CDC. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/fluvaxview/">https://www.cdc.gov/flu/fluvaxview/</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref037"><label>37</label><mixed-citation publication-type="other">Seasonal Influenza Vaccine Supply &#x00026; Distribution, CDC. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/qa/index.htm">https://www.cdc.gov/flu/about/qa/index.htm</ext-link> (accessed: 2019-03-06).</mixed-citation></ref><ref id="pcbi.1007111.ref038"><label>38</label><mixed-citation publication-type="other">Strategic National Stockpile, ASPR. <ext-link ext-link-type="uri" xlink:href="https://www.phe.gov/about/sns/Pages/default.aspx">https://www.phe.gov/about/sns/Pages/default.aspx</ext-link> (accessed: 2019-03-06).</mixed-citation></ref></ref-list></back></article>